Consequently, we validated our previous pilot study in a large and independent patient cohort, using standard FFPE tissue sections instead of cryosections, and confirmed the role of CCL20, TNF, and VEGFA expression by TAMs in predicting clinical behavior of primary cutaneous melanoma patients. The gene discussed is CCL20; the disease is cutaneous melanoma.